Effect of Simvastatin on Permeability in Cerebral Cavernous Malformation Type 1 Patients: Results from a Pilot Small Randomized Controlled Clinical Trial

Benzer Materyaller

• Familial Cerebral Cavernous Malformations
  Yazar:: Zafar, Atif, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Automated algorithm for counting microbleeds in patients with familial cerebral cavernous malformations
  Yazar:: Zou, Xiaowei, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity
  Yazar:: Choquet, Hélène, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• High Prevalence of Spinal Cord Cavernous Malformations in the Familial Cerebral Cavernous Malformations Type 1 Cohort
  Yazar:: Mabray, M.C., ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Association of cardiovascular risk factors with disease severity in cerebral cavernous malformation type 1 subjects with the common Hispanic mutation
  Yazar:: Choquet, Hélène, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)